BIO-TECHNE Corp Lessee, Operating Lease, Liability, to be Paid, Year One
BIO-TECHNE Corp (TECH) had Lessee, Operating Lease, Liability, to be Paid, Year One of $18.16 million as of 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-24
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $18.16M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $17.62M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $16.80M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $16.71M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $18.16M 10-K · filed 2026-08-24 |
| 2026-03-31 | $17.62M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $16.80M 10-Q · filed 2026-02-04 |
| 2025-09-30 | $16.71M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $17.68M 10-K · filed 2025-08-22 |
| 2025-03-31 | $17.05M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $16.57M 10-Q · filed 2025-02-06 |
| 2024-09-30 | $16.65M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $16.33M 10-K · filed 2024-08-22 |
| 2024-03-31 | $16.53M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $16.41M 10-Q · filed 2024-02-07 |
| 2023-09-30 | $15.93M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $15.17M 10-K · filed 2023-08-23 |
| 2023-03-31 | $13.46M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $13.24M 10-Q · filed 2023-02-07 |
| 2022-09-30 | $12.04M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $14.24M 10-K · filed 2022-08-24 |
| 2022-03-31 | $13.87M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $13.19M 10-Q · filed 2022-02-07 |
| 2021-09-30 | $13.57M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $14.35M 10-K · filed 2021-08-25 |
| 2021-03-31 | $13.08M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $12.45M 10-Q · filed 2021-02-08 |
| 2020-09-30 | $12.28M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $12.59M 10-K · filed 2020-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |